Education
About Us
Working with TipRanks
Follow Us
Alison Bauerlein Insider Profile
4 Followers
Alison Bauerlein, EVP, Finance, & CFO at Inogen, holds 620.53K shares in Sight Sciences (Ticker: SGHT), holds 71.43K shares in Pear Therapeutics (Ticker: PEARQ), holds 51.09K shares in Gelesis Holdings (Ticker: GLSHQ).
Profitable Transactions
9 out of 14 Profitable Transactions
Average Return
-7.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alison Bauerlein holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alison Bauerlein
Alison Bauerlein's Trading History
Inogen
Dec 03, 2021
EVP, Finance, & CFO
Uninformative Buy
1.66K
$240.03K
Pear Therapeutics
Feb 17, 2023
―
Uninformative Buy
―
$785.71
Gelesis Holdings
May 09, 2022
Director
Uninformative Buy
―
―
Sight Sciences
Nov 13, 2025
COO
Uninformative Buy
―
$5.19M
List of latest transactions for each holding click on a transaction to see Alison Bauerlein's performance on stock
You May Also Like
Alison Bauerlein insider profile FAQ
What is the percentage of profitable transactions made by Alison Bauerlein?
The percentage of profitable transactions made by Alison Bauerlein is 64%.
What is the average return per transaction made by Alison Bauerlein?
The average return per transaction made by Alison Bauerlein is -7.30%.
What stocks does Alison Bauerlein hold?
Alison Bauerlein holds: INGN, PEARQ, GLSHQ, SGHT stocks.
What was Alison Bauerlein’s latest transaction?
Alison Bauerlein latest transaction was an Uninformative Buy of ―.
What was Alison Bauerlein's most profitable transaction?
Alison Bauerlein’s most profitable transaction was an Informative Buy of INGN stock on April 29, 2014. The return on the trade was 170.60%.
What is Alison Bauerlein's role in Inogen?
Alison Bauerlein's role in Inogen is EVP, Finance, & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.